Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Clinical Trial ID NCT01757197

PubWeight™ 4.71‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01757197

Top papers

Rank Title Journal Year PubWeight™‹?›
1 IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 2014 1.27
2 Acute graft-versus-host disease: a bench-to-bedside update. Blood 2014 1.23
3 Tocilizumab in the treatment of rheumatoid arthritis and beyond. Drug Des Devel Ther 2014 0.97
4 Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? Blood 2016 0.78
5 Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease. Mucosal Immunol 2016 0.75
Next 100